How FDA panelists casting doubt on antidepressant use during pregnancy could lead to devastating outcomes for mothers
- Written by Nicole Amoyal Pensak, Researcher of Caregiver Stress Management and Clinical Psychologist, University of Colorado Anschutz Medical Campus

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake...